US EditionPublished • loading... • Updated
Victim Pushback Delays Purdue Pharma Opioid Sentencing
Summary by jdjournal.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Victim Pushback Delays Purdue Pharma Opioid Sentencing
The long-running opioid litigation against Purdue Pharma took another unexpected turn this week. A scheduled court proceeding tied to the company’s $5.5 billion resolution was delayed after victims appeared and demanded to be heard. The delay reflects growing tension between negotiated settlements and the voices of those directly affected. As a result, the case once again highlights the complexity of mass tort resolutions in high-profile public …
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
